Pfizer Inc (($PFE)) announced an update on their ongoing clinical study. Pfizer Inc. is conducting a Phase 1 study titled ‘A Study to Learn About ...
A series of recommended shots that health providers administer to children as they age has been a recent target of President ...
Eligibility for this vaccination is suddenly a timely question. A senior health editor reports on her real-time experience.
The adult-specific 21-valent pneumococcal conjugate vaccine was well tolerated and immunogenic across all 21 serotypes in patients with HIV infection.
Dear Savvy Senior, With a longtime vaccine critic leading the nation’s health departments, can you give me updated ...
Vaccine awareness, safety, and addressing misinformation are all important to improve adherence and public health outcomes, ...
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced positive results from the Phase 3 STRIDE-13 trial evaluating CAPVAXIVE® (Pneumococcal 21-valent Conjugate ...
The United States Adult Vaccine Market is projected to soar to US$ 11.10 billion by 2033, up from US$ 6.55 billion in 2024, ...
The shingles vaccine may cut dementia risk by up to 33%, per new research. Here, experts explain how it works and what it may ...
Infectious disease researchers found the vaccine, used to prevent herpes zoster, or shingles, is also linked to lower risks ...
Pfizer Inc (($PFE)) announced an update on their ongoing clinical study. Pfizer Inc. is conducting a Phase 4 study titled ‘A Phase 4 Study Using a ...